U.S. Military Sponsored Vaccine Trials and La Resistance in Nepal
by Jason Andrews

Giving Up on Gene Therapy Is Wrong Reaction
Death of Jolee Mohr should lead to new patient protections

by Arthur L. Caplan

Research Ethics
Human subjects in medical research
by Arthur L. Caplan, Glenn McGee

Is Gulf War syndrome II inevitable?
Have we done enough to protect our soldiers?
by Arthur L. Caplan

Research ban at Hopkins a sign of ethical crisis
The system for protecting human subjects research is not simply sick — it is dead
by Arthur L. Caplan

Compassionate Use of Experimental Drugs
The dilemma of whether or not to distribute one such "investigational drug" to a patient that does not fit the protocol of the federally funded clinical trial in which the hospital is participating.
by Tricha Shivas

More Articles...

Senator Moves to Block Medical Ghostwriting
Aug 20 (New York Times) A growing body of evidence suggests that doctors at some of the nation’s top medical schools have been attaching their names and lending their reputations to scientific papers that were drafted by ghostwriters working for drug companies — articles that were carefully calibrated to help the manufacturers sell more products.

Swine flu vaccine tests underway
Aug 10 (The Baltimore Sun) The University of Maryland kicked off its tests of the H1N1 vaccine this morning with 67 adult volunteers. It's one nine centers nationwide testing whether the shot is safe and effective. The trial is the first step in what could be a mass vaccination campaign to start in mid-October, as infectious disease experts anticipate a resurgence of the new flu.

Television Viewing Linked to Blood Pressure Increases in Children
Aug 06 (New York Times) Children who spend a lot of time watching television have higher blood pressure than those who watch less, even if the children are thin and get enough exercise, according to new research.

Lack of Study Volunteers May Hobble Cancer Fight
Aug 03 (New York Times) Not long ago, at a meeting of an advisory group established by Congress to monitor the war on cancer, participants were asked how to speed progress. The biggest barrier, in his opinion, was that almost no adult cancer patients — just 3 percent — participate in studies of cancer treatments, mostly new drugs or drug regimens.

Minorities Needed for Research Trials - Rochester Leads the Way
Jul 27 (13wham.com) The URMC is hoping to tackle a national phenomenon: too few minorities taking part in medical trials. Pick up a paper and you'll find part of an ad campaign new to Rochester. In fact, it's one of the first in the nation, and it is specifically aimed at racial minorities.

More News...